Safety Study of X-82 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2017

Conditions

Advanced Solid Tumors

Interventions

DRUG

X-82

Dose escalation starting at 20 mg, oral once or twice a day, 28 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.

Trial Locations (1)

Sarah Cannon Research Institute, Nashville